What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Enzyme
- Biochemistry
Her main research concerns Endocannabinoid system, Anandamide, Cannabinoid receptor, Biochemistry and Cannabinoid.
Her Endocannabinoid system research includes elements of Depolarization-induced suppression of inhibition, Neuroscience, Pharmacology and Rimonabant.
The concepts of her Anandamide study are interwoven with issues in AM404, Psychosis, Fatty acid, N-Acylphosphatidylethanolamine and Fatty acid amide hydrolase.
Her Fatty acid amide hydrolase research integrates issues from Stereochemistry and URB597.
In her research, Metabotropic glutamate receptor 6, Metabotropic glutamate receptor 7 and Metabotropic glutamate receptor is intimately related to Cell biology, which falls under the overarching field of Biochemistry.
Her research in Cannabinoid tackles topics such as Endocrinology which are related to areas like Oleoylethanolamide.
Her most cited work include:
- The molecular logic of endocannabinoid signalling (1564 citations)
- Formation and inactivation of endogenous cannabinoid anandamide in central neurons. (1371 citations)
- Role of Endogenous Cannabinoids in Synaptic Signaling (1329 citations)
What are the main themes of her work throughout her whole career to date?
Daniele Piomelli spends much of her time researching Endocannabinoid system, Biochemistry, Anandamide, Pharmacology and Internal medicine.
Daniele Piomelli focuses mostly in the field of Endocannabinoid system, narrowing it down to matters related to Cannabinoid receptor and, in some cases, Cannabinoid.
Her study looks at the relationship between Anandamide and topics such as Fatty acid amide hydrolase, which overlap with Stereochemistry.
Her Pharmacology study incorporates themes from Anesthesia, Hyperalgesia, Nociception, Agonist and Inflammation.
Her research investigates the connection between Internal medicine and topics such as Endocrinology that intersect with problems in Peroxisome proliferator-activated receptor.
Daniele Piomelli works mostly in the field of Oleoylethanolamide, limiting it down to concerns involving Palmitoylethanolamide and, occasionally, Amidase.
She most often published in these fields:
- Endocannabinoid system (46.78%)
- Biochemistry (37.42%)
- Anandamide (31.90%)
What were the highlights of her more recent work (between 2014-2021)?
- Biochemistry (37.42%)
- Endocannabinoid system (46.78%)
- Pharmacology (32.82%)
In recent papers she was focusing on the following fields of study:
Daniele Piomelli focuses on Biochemistry, Endocannabinoid system, Pharmacology, Internal medicine and Fatty acid amide hydrolase.
Her research in Endocannabinoid system intersects with topics in Anandamide, Cannabinoid receptor and Neuroscience.
Her Anandamide research is multidisciplinary, relying on both URB597 and Migraine.
As part of the same scientific family, Daniele Piomelli usually focuses on Cannabinoid receptor, concentrating on Cannabinoid and intersecting with Cannabinoid receptor type 2.
Her work deals with themes such as Inflammation, Anesthesia and Hyperalgesia, Nociception, which intersect with Pharmacology.
As part of one scientific family, Daniele Piomelli deals mainly with the area of Internal medicine, narrowing it down to issues related to the Endocrinology, and often Oleoylethanolamide.
Between 2014 and 2021, her most popular works were:
- Endocannabinoid signaling mediates oxytocin-driven social reward (99 citations)
- Endocannabinoid signaling mediates oxytocin-driven social reward (99 citations)
- TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice (75 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
